Selectivity data for probe A-192621 and control A-1806262
A-192621
Compound concentration: 10 µM| Receptor | HGNC target name | Inhibition [%] (Primary experimental value) | Ki [nM] (Secondary experimental value) | pKi |
|---|---|---|---|---|
| GABAA/BZP | 5.57 | |||
| Beta3 | ADRB3 | 13.26 | ||
| H2 | HRH2 | 5.77 | ||
| H4 | HRH4 | 7.94 | ||
| SERT | SLC6A4 | 10.58 | ||
| 5-HT1D | HTR1D | -3.09 | ||
| 5-HT1E | HTR1E | -15.32 | ||
| 5-HT2A | HTR2A | 4.84 | ||
| 5-HT3 | HTR3A | -5.22 | ||
| D4 | DRD4 | -3.59 | ||
| D5 | DRD5 | 11.02 | ||
| DOR | OPRD1 | 9.89 | ||
| KOR | OPRK1 | 35.26 | ||
| GABA/PBR | 16.50 | |||
| 5-HT1A | HTR1A | -16.72 | ||
| 5-HT5A | HTR5A | -0.22 | ||
| 5-HT6 | HTR6 | -17.83 | ||
| Alpha2A | ADRA2A | 9.55 | ||
| Alpha2C | ADRA2C | 0.50 | ||
| D2 | DRD2 | -11.92 | ||
| GABAA | 19.63 | |||
| H3 | HRH3 | -16.70 | ||
| M5 | CHRM5 | 27.26 | ||
| MOR | OPRM1 | 6.79 | ||
| NET | SLC6A2 | -17.48 | ||
| Sigma 1 | SIGMAR1 | 4.29 | ||
| 5-HT1B | HTR1B | 4.31 | ||
| 5-HT2B | HTR2B | 12.85 | ||
| 5-HT2C | HTR2C | -5.44 | ||
| Alpha1A | ADRA1A | -9.09 | ||
| Alpha1B | ADRA1B | -2.22 | ||
| Alpha1D | ADRA1D | -1.79 | ||
| Alpha2B | ADRA2B | 10.42 | ||
| D3 | DRD3 | -5.43 | ||
| DAT | SLC6A3 | -20.11 | ||
| M1 | CHRM1 | -16.29 | ||
| M2 | CHRM2 | -5.30 | ||
| Sigma 2 | TMEM97 | -7.10 | ||
| 5-HT7A | HTR7 | -3.72 | ||
| D1 | DRD1 | 17.32 | ||
| H1 | HRH1 | 35.99 | ||
| M3 | CHRM3 | -5.06 | ||
| M4 | CHRM4 | 12.48 |
A-192621
| HGNC target name | DiscoverX gene symbol of kinase | % Control | Compound Concentration [nM] | Kd [nM] | AAK1 | AAK1 | 95.0 | 1000 | ABL1 | ABL1-phosphorylated | 73.0 | 1000 | ABL2 | ABL2 | 100.0 | 1000 | ACVR1 | ACVR1 | 100.0 | 1000 | ACVR1B | ACVR1B | 99.0 | 1000 | ACVR2A | ACVR2A | 100.0 | 1000 | ACVR2B | ACVR2B | 93.0 | 1000 | ACVRL1 | ACVRL1 | 99.0 | 1000 | COQ8A | ADCK3 | 100.0 | 1000 | COQ8B | ADCK4 | 90.0 | 1000 | AKT1 | AKT1 | 97.0 | 1000 | AKT2 | AKT2 | 100.0 | 1000 | AKT3 | AKT3 | 82.0 | 1000 | ALK | ALK(L1196M) | 91.0 | 1000 | PRKAA1 | AMPK-alpha1 | 100.0 | 1000 | PRKAA2 | AMPK-alpha2 | 100.0 | 1000 | ANKK1 | ANKK1 | 65.0 | 1000 | NUAK1 | ARK5 | 83.0 | 1000 | MAP3K5 | ASK1 | 91.0 | 1000 | MAP3K6 | ASK2 | 65.0 | 1000 | AURKA | AURKA | 93.0 | 1000 | AURKB | AURKB | 72.0 | 1000 | AURKC | AURKC | 91.0 | 1000 | AXL | AXL | 83.0 | 1000 | BMP2K | BIKE | 87.0 | 1000 | BLK | BLK | 88.0 | 1000 | BMPR1A | BMPR1A | 100.0 | 1000 | BMPR1B | BMPR1B | 61.0 | 1000 | BMPR2 | BMPR2 | 53.0 | 1000 | BMX | BMX | 100.0 | 1000 | BRAF | BRAF(V600E) | 76.0 | 1000 | PTK6 | BRK | 84.0 | 1000 | BRSK1 | BRSK1 | 100.0 | 1000 | BRSK2 | BRSK2 | 97.0 | 1000 | BTK | BTK | 55.0 | 1000 | BUB1 | BUB1 | 98.0 | 1000 | CAMK1 | CAMK1 | 93.0 | 1000 | PNCK | CAMK1B | 77.0 | 1000 | CAMK1D | CAMK1D | 75.0 | 1000 | CAMK1G | CAMK1G | 90.0 | 1000 | CAMK2A | CAMK2A | 90.0 | 1000 | CAMK2B | CAMK2B | 99.0 | 1000 | CAMK2D | CAMK2D | 93.0 | 1000 | CAMK2G | CAMK2G | 95.0 | 1000 | CAMK4 | CAMK4 | 89.0 | 1000 | CAMKK1 | CAMKK1 | 86.0 | 1000 | CAMKK2 | CAMKK2 | 93.0 | 1000 | CASK | CASK | 77.0 | 1000 | CDK11B | CDC2L1 | 100.0 | 1000 | CDK11A | CDC2L2 | 98.0 | 1000 | CDK13 | CDC2L5 | 45.0 | 1000 | CDK19 | CDK11 | 95.0 | 1000 | CDK2 | CDK2 | 87.0 | 1000 | CDK3 | CDK3 | 95.0 | 1000 | CDK4 | CDK4-cyclinD3 | 89.0 | 1000 | CDK5 | CDK5 | 100.0 | 1000 | CDK7 | CDK7 | 78.0 | 1000 | CDK8 | CDK8 | 76.0 | 1000 | CDK9 | CDK9 | 88.0 | 1000 | CDKL1 | CDKL1 | 66.0 | 1000 | CDKL2 | CDKL2 | 84.0 | 1000 | CDKL3 | CDKL3 | 92.0 | 1000 | CDKL5 | CDKL5 | 85.0 | 1000 | CHEK1 | CHEK1 | 98.0 | 1000 | CHEK2 | CHEK2 | 88.0 | 1000 | CIT | CIT | 83.0 | 1000 | CLK1 | CLK1 | 87.0 | 1000 | CLK2 | CLK2 | 91.0 | 1000 | CLK3 | CLK3 | 97.0 | 1000 | CLK4 | CLK4 | 100.0 | 1000 | CSF1R | CSF1R-autoinhibited | 61.0 | 1000 | CSK | CSK | 80.0 | 1000 | CSNK1A1 | CSNK1A1 | 72.0 | 1000 | CSNK1A1L | CSNK1A1L | 92.0 | 1000 | CSNK1D | CSNK1D | 80.0 | 1000 | CSNK1E | CSNK1E | 100.0 | 1000 | CSNK1G1 | CSNK1G1 | 100.0 | 1000 | CSNK1G2 | CSNK1G2 | 100.0 | 1000 | CSNK1G3 | CSNK1G3 | 100.0 | 1000 | CSNK2A1 | CSNK2A1 | 69.0 | 1000 | CSNK2A2 | CSNK2A2 | 87.0 | 1000 | MATK | CTK | 83.0 | 1000 | DAPK1 | DAPK1 | 90.0 | 1000 | DAPK2 | DAPK2 | 100.0 | 1000 | DAPK3 | DAPK3 | 89.0 | 1000 | DCLK1 | DCAMKL1 | 75.0 | 1000 | DCLK2 | DCAMKL2 | 77.0 | 1000 | DCLK3 | DCAMKL3 | 100.0 | 1000 | DDR1 | DDR1 | 100.0 | 1000 | DDR2 | DDR2 | 71.0 | 1000 | MAP3K12 | DLK | 52.0 | 1000 | DMPK | DMPK | 81.0 | 1000 | CDC42BPG | DMPK2 | 79.0 | 1000 | STK17A | DRAK1 | 92.0 | 1000 | STK17B | DRAK2 | 91.0 | 1000 | DYRK1A | DYRK1A | 73.0 | 1000 | DYRK1B | DYRK1B | 100.0 | 1000 | DYRK2 | DYRK2 | 74.0 | 1000 | EGFR | EGFR(T790M) | 82.0 | 1000 | EIF2AK1 | EIF2AK1 | 84.0 | 1000 | EPHA1 | EPHA1 | 86.0 | 1000 | EPHA2 | EPHA2 | 100.0 | 1000 | EPHA3 | EPHA3 | 86.0 | 1000 | EPHA4 | EPHA4 | 97.0 | 1000 | EPHA5 | EPHA5 | 100.0 | 1000 | EPHA6 | EPHA6 | 100.0 | 1000 | EPHA7 | EPHA7 | 98.0 | 1000 | EPHA8 | EPHA8 | 98.0 | 1000 | EPHB1 | EPHB1 | 100.0 | 1000 | EPHB2 | EPHB2 | 100.0 | 1000 | EPHB3 | EPHB3 | 97.0 | 1000 | EPHB4 | EPHB4 | 100.0 | 1000 | EPHB6 | EPHB6 | 65.0 | 1000 | ERBB2 | ERBB2 | 79.0 | 1000 | ERBB3 | ERBB3 | 78.0 | 1000 | ERBB4 | ERBB4 | 100.0 | 1000 | MAPK3 | ERK1 | 93.0 | 1000 | MAPK1 | ERK2 | 100.0 | 1000 | MAPK6 | ERK3 | 92.0 | 1000 | MAPK4 | ERK4 | 93.0 | 1000 | MAPK7 | ERK5 | 97.0 | 1000 | MAPK15 | ERK8 | 100.0 | 1000 | ERN1 | ERN1 | 86.0 | 1000 | PTK2 | FAK | 86.0 | 1000 | FER | FER | 100.0 | 1000 | FES | FES | 96.0 | 1000 | FGFR1 | FGFR1 | 100.0 | 1000 | FGFR2 | FGFR2 | 100.0 | 1000 | FGFR3 | FGFR3(G697C) | 85.0 | 1000 | FGFR4 | FGFR4 | 87.0 | 1000 | FGR | FGR | 98.0 | 1000 | FLT1 | FLT1 | 97.0 | 1000 | FLT3 | FLT3-autoinhibited | 80.0 | 1000 | FLT4 | FLT4 | 90.0 | 1000 | FRK | FRK | 100.0 | 1000 | FYN | FYN | 100.0 | 1000 | GAK | GAK | 93.0 | 1000 | EIF2AK4 | GCN2(Kin.Dom.2,S808G) | 90.0 | 1000 | GRK1 | GRK1 | 68.0 | 1000 | GRK2 | GRK2 | 51.0 | 1000 | GRK3 | GRK3 | 73.0 | 1000 | GRK4 | GRK4 | 100.0 | 1000 | GRK7 | GRK7 | 100.0 | 1000 | GSK3A | GSK3A | 86.0 | 1000 | GSK3B | GSK3B | 73.0 | 1000 | HASPIN | HASPIN | 62.0 | 1000 | HCK | HCK | 92.0 | 1000 | HIPK1 | HIPK1 | 75.0 | 1000 | HIPK2 | HIPK2 | 66.0 | 1000 | HIPK3 | HIPK3 | 74.0 | 1000 | HIPK4 | HIPK4 | 70.0 | 1000 | MAP4K1 | HPK1 | 92.0 | 1000 | HUNK | HUNK | 100.0 | 1000 | CILK1 | ICK | 59.0 | 1000 | IGF1R | IGF1R | 89.0 | 1000 | CHUK | IKK-alpha | 77.0 | 1000 | IKBKB | IKK-beta | 77.0 | 1000 | IKBKE | IKK-epsilon | 68.0 | 1000 | INSR | INSR | 74.0 | 1000 | INSRR | INSRR | 94.0 | 1000 | IRAK1 | IRAK1 | 67.0 | 1000 | IRAK3 | IRAK3 | 100.0 | 1000 | IRAK4 | IRAK4 | 76.0 | 1000 | ITK | ITK | 96.0 | 1000 | JAK1 | JAK1(JH2domain-pseudokinase) | 94.0 | 1000 | JAK2 | JAK2(JH1domain-catalytic) | 53.0 | 1000 | JAK3 | JAK3(JH1domain-catalytic) | 84.0 | 1000 | MAPK8 | JNK1 | 70.0 | 1000 | MAPK9 | JNK2 | 65.0 | 1000 | MAPK10 | JNK3 | 80.0 | 1000 | KIT | KIT-autoinhibited | 92.0 | 1000 | LATS1 | LATS1 | 77.0 | 1000 | LATS2 | LATS2 | 97.0 | 1000 | LCK | LCK | 100.0 | 1000 | LIMK1 | LIMK1 | 100.0 | 1000 | LIMK2 | LIMK2 | 100.0 | 1000 | STK11 | LKB1 | 88.0 | 1000 | STK10 | LOK | 97.0 | 1000 | LRRK2 | LRRK2(G2019S) | 91.0 | 1000 | LTK | LTK | 100.0 | 1000 | LYN | LYN | 90.0 | 1000 | MAP3K13 | LZK | 47.0 | 1000 | MAK | MAK | 97.0 | 1000 | MAP3K1 | MAP3K1 | 71.0 | 1000 | MAP3K15 | MAP3K15 | 73.0 | 1000 | MAP3K2 | MAP3K2 | 82.0 | 1000 | MAP3K3 | MAP3K3 | 74.0 | 1000 | MAP3K4 | MAP3K4 | 88.0 | 1000 | MAP4K2 | MAP4K2 | 79.0 | 1000 | MAP4K3 | MAP4K3 | 85.0 | 1000 | MAP4K4 | MAP4K4 | 90.0 | 1000 | MAP4K5 | MAP4K5 | 93.0 | 1000 | MAPKAPK2 | MAPKAPK2 | 100.0 | 1000 | MAPKAPK5 | MAPKAPK5 | 65.0 | 1000 | MARK1 | MARK1 | 100.0 | 1000 | MARK2 | MARK2 | 88.0 | 1000 | MARK3 | MARK3 | 100.0 | 1000 | MARK4 | MARK4 | 97.0 | 1000 | MAST1 | MAST1 | 93.0 | 1000 | MAP2K1 | MEK1 | 66.0 | 1000 | MAP2K2 | MEK2 | 62.0 | 1000 | MAP2K3 | MEK3 | 60.0 | 1000 | MAP2K4 | MEK4 | 80.0 | 1000 | MAP2K5 | MEK5 | 63.0 | 1000 | MAP2K6 | MEK6 | 100.0 | 1000 | MELK | MELK | 65.0 | 1000 | MERTK | MERTK | 87.0 | 1000 | MET | MET(Y1235D) | 100.0 | 1000 | MINK1 | MINK | 68.0 | 1000 | MAP2K7 | MKK7 | 74.0 | 1000 | MKNK1 | MKNK1 | 65.0 | 1000 | MKNK2 | MKNK2 | 74.0 | 1000 | MYLK3 | MLCK | 86.0 | 1000 | MAP3K9 | MLK1 | 93.0 | 1000 | MAP3K10 | MLK2 | 100.0 | 1000 | MAP3K11 | MLK3 | 100.0 | 1000 | CDC42BPA | MRCKA | 94.0 | 1000 | CDC42BPB | MRCKB | 87.0 | 1000 | STK4 | MST1 | 99.0 | 1000 | MST1R | MST1R | 86.0 | 1000 | STK3 | MST2 | 96.0 | 1000 | STK24 | MST3 | 84.0 | 1000 | STK26 | MST4 | 74.0 | 1000 | MTOR | MTOR | 77.0 | 1000 | MUSK | MUSK | 82.0 | 1000 | MYLK | MYLK | 85.0 | 1000 | MYLK2 | MYLK2 | 91.0 | 1000 | MYLK4 | MYLK4 | 75.0 | 1000 | MYO3A | MYO3A | 100.0 | 1000 | MYO3B | MYO3B | 66.0 | 1000 | STK38 | NDR1 | 77.0 | 1000 | STK38L | NDR2 | 88.0 | 1000 | NEK1 | NEK1 | 87.0 | 1000 | NEK10 | NEK10 | 82.0 | 1000 | NEK11 | NEK11 | 59.0 | 1000 | NEK2 | NEK2 | 90.0 | 1000 | NEK3 | NEK3 | 69.0 | 1000 | NEK4 | NEK4 | 71.0 | 1000 | NEK5 | NEK5 | 29.0 | 1000 | NEK6 | NEK6 | 96.0 | 1000 | NEK7 | NEK7 | 96.0 | 1000 | NEK9 | NEK9 | 95.0 | 1000 | MAP3K14 | NIK | 85.0 | 1000 | NIM1K | NIM1 | 78.0 | 1000 | NLK | NLK | 100.0 | 1000 | OXSR1 | OSR1 | 75.0 | 1000 | MAPK14 | p38-alpha | 99.0 | 1000 | MAPK11 | p38-beta | 95.0 | 1000 | MAPK13 | p38-delta | 92.0 | 1000 | MAPK12 | p38-gamma | 73.0 | 1000 | PAK1 | PAK1 | 89.0 | 1000 | PAK2 | PAK2 | 94.0 | 1000 | PAK3 | PAK3 | 100.0 | 1000 | PAK4 | PAK4 | 91.0 | 1000 | PAK6 | PAK6 | 68.0 | 1000 | PAK5 | PAK7 | 73.0 | 1000 | CDK16 | PCTK1 | 77.0 | 1000 | CDK17 | PCTK2 | 91.0 | 1000 | CDK18 | PCTK3 | 100.0 | 1000 | PDGFRA | PDGFRA | 80.0 | 1000 | PDGFRB | PDGFRB | 100.0 | 1000 | PDPK1 | PDPK1 | 100.0 | 1000 | CDPK1 | PFCDPK1(P.falciparum) | 88.0 | 1000 | PK5 | PFPK5(P.falciparum) | 87.0 | 1000 | CDK15 | PFTAIRE2 | 94.0 | 1000 | CDK14 | PFTK1 | 100.0 | 1000 | PHKG1 | PHKG1 | 99.0 | 1000 | PHKG2 | PHKG2 | 86.0 | 1000 | PIK3C2B | PIK3C2B | 92.0 | 1000 | PIK3C2G | PIK3C2G | 75.0 | 1000 | PIK3CA | PIK3CA(Q546K) | 69.0 | 1000 | PIK3CB | PIK3CB | 73.0 | 1000 | PIK3CD | PIK3CD | 75.0 | 1000 | PIK3CG | PIK3CG | 68.0 | 1000 | PI4KB | PIK4CB | 75.0 | 1000 | PIKFYVE | PIKFYVE | 86.0 | 1000 | PIM1 | PIM1 | 85.0 | 1000 | PIM2 | PIM2 | 91.0 | 1000 | PIM3 | PIM3 | 88.0 | 1000 | PIP5K1A | PIP5K1A | 82.0 | 1000 | PIP5K1C | PIP5K1C | 100.0 | 1000 | PIP4K2B | PIP5K2B | 97.0 | 1000 | PIP4K2C | PIP5K2C | 49.0 | 1000 | PRKACA | PKAC-alpha | 100.0 | 1000 | PRKACB | PKAC-beta | 87.0 | 1000 | PKMYT1 | PKMYT1 | 74.0 | 1000 | PKN1 | PKN1 | 87.0 | 1000 | PKN2 | PKN2 | 100.0 | 1000 | PKNB | PKNB(M.tuberculosis) | 78.0 | 1000 | PLK1 | PLK1 | 80.0 | 1000 | PLK2 | PLK2 | 79.0 | 1000 | PLK3 | PLK3 | 83.0 | 1000 | PLK4 | PLK4 | 78.0 | 1000 | PRKCD | PRKCD | 100.0 | 1000 | PRKCE | PRKCE | 74.0 | 1000 | PRKCH | PRKCH | 100.0 | 1000 | PRKCI | PRKCI | 78.0 | 1000 | PRKCQ | PRKCQ | 81.0 | 1000 | PRKD1 | PRKD1 | 94.0 | 1000 | PRKD2 | PRKD2 | 84.0 | 1000 | PRKD3 | PRKD3 | 93.0 | 1000 | PRKG1 | PRKG1 | 88.0 | 1000 | PRKG2 | PRKG2 | 82.0 | 1000 | EIF2AK2 | PRKR | 100.0 | 1000 | PRKX | PRKX | 91.0 | 1000 | PRPF4B | PRP4 | 82.0 | 1000 | PTK2B | PYK2 | 98.0 | 1000 | SIK3 | QSK | 71.0 | 1000 | RAF1 | RAF1 | 98.0 | 1000 | RET | RET(V804M) | 100.0 | 1000 | RIOK1 | RIOK1 | 86.0 | 1000 | RIOK2 | RIOK2 | 71.0 | 1000 | RIOK3 | RIOK3 | 100.0 | 1000 | RIPK1 | RIPK1 | 88.0 | 1000 | RIPK2 | RIPK2 | 100.0 | 1000 | RIPK4 | RIPK4 | 69.0 | 1000 | DSTYK | RIPK5 | 73.0 | 1000 | ROCK1 | ROCK1 | 65.0 | 1000 | ROCK2 | ROCK2 | 69.0 | 1000 | ROS1 | ROS1 | 98.0 | 1000 | RPS6KA4 | RPS6KA4(Kin.Dom.2-C-terminal) | 68.0 | 1000 | RPS6KA5 | RPS6KA5(Kin.Dom.2-C-terminal) | 89.0 | 1000 | RPS6KA1 | RSK1(Kin.Dom.2-C-terminal) | 74.0 | 1000 | RPS6KA3 | RSK2(Kin.Dom.2-C-terminal) | 73.0 | 1000 | RPS6KA2 | RSK3(Kin.Dom.2-C-terminal) | 82.0 | 1000 | RPS6KA6 | RSK4(Kin.Dom.2-C-terminal) | 77.0 | 1000 | RPS6KB1 | S6K1 | 76.0 | 1000 | SBK1 | SBK1 | 78.0 | 1000 | SGK1 | SGK | 63.0 | 1000 | SBK3 | SgK110 | 94.0 | 1000 | SGK2 | SGK2 | 54.0 | 1000 | SGK3 | SGK3 | 63.0 | 1000 | SIK1 | SIK | 100.0 | 1000 | SIK2 | SIK2 | 89.0 | 1000 | SLK | SLK | 100.0 | 1000 | NUAK2 | SNARK | 57.0 | 1000 | SNRK | SNRK | 84.0 | 1000 | SRC | SRC | 99.0 | 1000 | SRMS | SRMS | 63.0 | 1000 | SRPK1 | SRPK1 | 95.0 | 1000 | SRPK2 | SRPK2 | 96.0 | 1000 | SRPK3 | SRPK3 | 100.0 | 1000 | STK16 | STK16 | 72.0 | 1000 | STK33 | STK33 | 65.0 | 1000 | STK35 | STK35 | 92.0 | 1000 | STK36 | STK36 | 98.0 | 1000 | STK39 | STK39 | 58.0 | 1000 | SYK | SYK | 100.0 | 1000 | MAP3K7 | TAK1 | 100.0 | 1000 | TAOK1 | TAOK1 | 84.0 | 1000 | TAOK2 | TAOK2 | 74.0 | 1000 | TAOK3 | TAOK3 | 81.0 | 1000 | TBK1 | TBK1 | 91.0 | 1000 | TEC | TEC | 100.0 | 1000 | TESK1 | TESK1 | 89.0 | 1000 | TGFBR1 | TGFBR1 | 64.0 | 1000 | TGFBR2 | TGFBR2 | 95.0 | 1000 | TIE1 | TIE1 | 94.0 | 1000 | TEK | TIE2 | 100.0 | 1000 | TLK1 | TLK1 | 74.0 | 1000 | TLK2 | TLK2 | 94.0 | 1000 | TNIK | TNIK | 88.0 | 1000 | TNK1 | TNK1 | 100.0 | 1000 | TNK2 | TNK2 | 100.0 | 1000 | TNNI3K | TNNI3K | 100.0 | 1000 | NTRK1 | TRKA | 84.0 | 1000 | NTRK2 | TRKB | 85.0 | 1000 | NTRK3 | TRKC | 71.0 | 1000 | TRPM6 | TRPM6 | 94.0 | 1000 | TSSK1B | TSSK1B | 92.0 | 1000 | TSSK3 | TSSK3 | 58.0 | 1000 | TTK | TTK | 94.0 | 1000 | TXK | TXK | 85.0 | 1000 | TYK2 | TYK2(JH2domain-pseudokinase) | 80.0 | 1000 | TYRO3 | TYRO3 | 100.0 | 1000 | ULK1 | ULK1 | 68.0 | 1000 | ULK2 | ULK2 | 55.0 | 1000 | ULK3 | ULK3 | 72.0 | 1000 | KDR | VEGFR2 | 77.0 | 1000 | PIK3C3 | VPS34 | 78.0 | 1000 | VRK2 | VRK2 | 61.0 | 1000 | WEE1 | WEE1 | 93.0 | 1000 | WEE2 | WEE2 | 85.0 | 1000 | WNK1 | WNK1 | 89.0 | 1000 | WNK2 | WNK2 | 58.0 | 1000 | WNK3 | WNK3 | 90.0 | 1000 | WNK4 | WNK4 | 81.0 | 1000 | STK32A | YANK1 | 93.0 | 1000 | STK32B | YANK2 | 100.0 | 1000 | STK32C | YANK3 | 100.0 | 1000 | YES1 | YES | 99.0 | 1000 | STK25 | YSK1 | 100.0 | 1000 | MAP3K19 | YSK4 | 77.0 | 1000 | MAP3K20 | ZAK | 90.0 | 1000 | ZAP70 | ZAP70 | 50.0 | 1000 |
|---|
A-1806262
| HGNC target name | DiscoverX gene symbol of kinase | % Control | Compound Concentration [nM] | Kd [nM] | AAK1 | AAK1 | 90.0 | 1000 | ABL1 | ABL1-phosphorylated | 80.0 | 1000 | ABL2 | ABL2 | 96.0 | 1000 | ACVR1 | ACVR1 | 95.0 | 1000 | ACVR1B | ACVR1B | 90.0 | 1000 | ACVR2A | ACVR2A | 100.0 | 1000 | ACVR2B | ACVR2B | 96.0 | 1000 | ACVRL1 | ACVRL1 | 100.0 | 1000 | COQ8A | ADCK3 | 100.0 | 1000 | COQ8B | ADCK4 | 89.0 | 1000 | AKT1 | AKT1 | 100.0 | 1000 | AKT2 | AKT2 | 100.0 | 1000 | AKT3 | AKT3 | 100.0 | 1000 | ALK | ALK(L1196M) | 78.0 | 1000 | PRKAA1 | AMPK-alpha1 | 96.0 | 1000 | PRKAA2 | AMPK-alpha2 | 95.0 | 1000 | ANKK1 | ANKK1 | 73.0 | 1000 | NUAK1 | ARK5 | 99.0 | 1000 | MAP3K5 | ASK1 | 97.0 | 1000 | MAP3K6 | ASK2 | 77.0 | 1000 | AURKA | AURKA | 94.0 | 1000 | AURKB | AURKB | 77.0 | 1000 | AURKC | AURKC | 94.0 | 1000 | AXL | AXL | 93.0 | 1000 | BMP2K | BIKE | 92.0 | 1000 | BLK | BLK | 96.0 | 1000 | BMPR1A | BMPR1A | 89.0 | 1000 | BMPR1B | BMPR1B | 82.0 | 1000 | BMPR2 | BMPR2 | 69.0 | 1000 | BMX | BMX | 100.0 | 1000 | BRAF | BRAF(V600E) | 98.0 | 1000 | PTK6 | BRK | 83.0 | 1000 | BRSK1 | BRSK1 | 100.0 | 1000 | BRSK2 | BRSK2 | 100.0 | 1000 | BTK | BTK | 72.0 | 1000 | BUB1 | BUB1 | 92.0 | 1000 | CAMK1 | CAMK1 | 100.0 | 1000 | PNCK | CAMK1B | 100.0 | 1000 | CAMK1D | CAMK1D | 97.0 | 1000 | CAMK1G | CAMK1G | 89.0 | 1000 | CAMK2A | CAMK2A | 100.0 | 1000 | CAMK2B | CAMK2B | 88.0 | 1000 | CAMK2D | CAMK2D | 88.0 | 1000 | CAMK2G | CAMK2G | 88.0 | 1000 | CAMK4 | CAMK4 | 96.0 | 1000 | CAMKK1 | CAMKK1 | 81.0 | 1000 | CAMKK2 | CAMKK2 | 84.0 | 1000 | CASK | CASK | 89.0 | 1000 | CDK11B | CDC2L1 | 94.0 | 1000 | CDK11A | CDC2L2 | 100.0 | 1000 | CDK13 | CDC2L5 | 81.0 | 1000 | CDK19 | CDK11 | 89.0 | 1000 | CDK2 | CDK2 | 87.0 | 1000 | CDK3 | CDK3 | 100.0 | 1000 | CDK4 | CDK4-cyclinD3 | 96.0 | 1000 | CDK5 | CDK5 | 100.0 | 1000 | CDK7 | CDK7 | 86.0 | 1000 | CDK8 | CDK8 | 86.0 | 1000 | CDK9 | CDK9 | 87.0 | 1000 | CDKL1 | CDKL1 | 77.0 | 1000 | CDKL2 | CDKL2 | 96.0 | 1000 | CDKL3 | CDKL3 | 95.0 | 1000 | CDKL5 | CDKL5 | 83.0 | 1000 | CHEK1 | CHEK1 | 86.0 | 1000 | CHEK2 | CHEK2 | 98.0 | 1000 | CIT | CIT | 98.0 | 1000 | CLK1 | CLK1 | 93.0 | 1000 | CLK2 | CLK2 | 100.0 | 1000 | CLK3 | CLK3 | 93.0 | 1000 | CLK4 | CLK4 | 89.0 | 1000 | CSF1R | CSF1R-autoinhibited | 90.0 | 1000 | CSK | CSK | 91.0 | 1000 | CSNK1A1 | CSNK1A1 | 73.0 | 1000 | CSNK1A1L | CSNK1A1L | 94.0 | 1000 | CSNK1D | CSNK1D | 83.0 | 1000 | CSNK1E | CSNK1E | 98.0 | 1000 | CSNK1G1 | CSNK1G1 | 97.0 | 1000 | CSNK1G2 | CSNK1G2 | 96.0 | 1000 | CSNK1G3 | CSNK1G3 | 100.0 | 1000 | CSNK2A1 | CSNK2A1 | 100.0 | 1000 | CSNK2A2 | CSNK2A2 | 83.0 | 1000 | MATK | CTK | 90.0 | 1000 | DAPK1 | DAPK1 | 83.0 | 1000 | DAPK2 | DAPK2 | 80.0 | 1000 | DAPK3 | DAPK3 | 79.0 | 1000 | DCLK1 | DCAMKL1 | 80.0 | 1000 | DCLK2 | DCAMKL2 | 85.0 | 1000 | DCLK3 | DCAMKL3 | 100.0 | 1000 | DDR1 | DDR1 | 89.0 | 1000 | DDR2 | DDR2 | 74.0 | 1000 | MAP3K12 | DLK | 100.0 | 1000 | DMPK | DMPK | 86.0 | 1000 | CDC42BPG | DMPK2 | 57.0 | 1000 | STK17A | DRAK1 | 92.0 | 1000 | STK17B | DRAK2 | 93.0 | 1000 | DYRK1A | DYRK1A | 86.0 | 1000 | DYRK1B | DYRK1B | 99.0 | 1000 | DYRK2 | DYRK2 | 92.0 | 1000 | EGFR | EGFR(T790M) | 93.0 | 1000 | EIF2AK1 | EIF2AK1 | 86.0 | 1000 | EPHA1 | EPHA1 | 100.0 | 1000 | EPHA2 | EPHA2 | 100.0 | 1000 | EPHA3 | EPHA3 | 99.0 | 1000 | EPHA4 | EPHA4 | 75.0 | 1000 | EPHA5 | EPHA5 | 100.0 | 1000 | EPHA6 | EPHA6 | 98.0 | 1000 | EPHA7 | EPHA7 | 92.0 | 1000 | EPHA8 | EPHA8 | 97.0 | 1000 | EPHB1 | EPHB1 | 91.0 | 1000 | EPHB2 | EPHB2 | 100.0 | 1000 | EPHB3 | EPHB3 | 96.0 | 1000 | EPHB4 | EPHB4 | 96.0 | 1000 | EPHB6 | EPHB6 | 77.0 | 1000 | ERBB2 | ERBB2 | 80.0 | 1000 | ERBB3 | ERBB3 | 84.0 | 1000 | ERBB4 | ERBB4 | 100.0 | 1000 | MAPK3 | ERK1 | 93.0 | 1000 | MAPK1 | ERK2 | 100.0 | 1000 | MAPK6 | ERK3 | 59.0 | 1000 | MAPK4 | ERK4 | 95.0 | 1000 | MAPK7 | ERK5 | 93.0 | 1000 | MAPK15 | ERK8 | 100.0 | 1000 | ERN1 | ERN1 | 90.0 | 1000 | PTK2 | FAK | 88.0 | 1000 | FER | FER | 100.0 | 1000 | FES | FES | 97.0 | 1000 | FGFR1 | FGFR1 | 100.0 | 1000 | FGFR2 | FGFR2 | 100.0 | 1000 | FGFR3 | FGFR3(G697C) | 99.0 | 1000 | FGFR4 | FGFR4 | 93.0 | 1000 | FGR | FGR | 93.0 | 1000 | FLT1 | FLT1 | 94.0 | 1000 | FLT3 | FLT3-autoinhibited | 71.0 | 1000 | FLT4 | FLT4 | 100.0 | 1000 | FRK | FRK | 89.0 | 1000 | FYN | FYN | 87.0 | 1000 | GAK | GAK | 98.0 | 1000 | EIF2AK4 | GCN2(Kin.Dom.2,S808G) | 100.0 | 1000 | GRK1 | GRK1 | 100.0 | 1000 | GRK2 | GRK2 | 89.0 | 1000 | GRK3 | GRK3 | 100.0 | 1000 | GRK4 | GRK4 | 100.0 | 1000 | GRK7 | GRK7 | 99.0 | 1000 | GSK3A | GSK3A | 100.0 | 1000 | GSK3B | GSK3B | 100.0 | 1000 | HASPIN | HASPIN | 99.0 | 1000 | HCK | HCK | 92.0 | 1000 | HIPK1 | HIPK1 | 79.0 | 1000 | HIPK2 | HIPK2 | 80.0 | 1000 | HIPK3 | HIPK3 | 85.0 | 1000 | HIPK4 | HIPK4 | 65.0 | 1000 | MAP4K1 | HPK1 | 92.0 | 1000 | HUNK | HUNK | 70.0 | 1000 | CILK1 | ICK | 100.0 | 1000 | IGF1R | IGF1R | 88.0 | 1000 | CHUK | IKK-alpha | 86.0 | 1000 | IKBKB | IKK-beta | 94.0 | 1000 | IKBKE | IKK-epsilon | 85.0 | 1000 | INSR | INSR | 89.0 | 1000 | INSRR | INSRR | 100.0 | 1000 | IRAK1 | IRAK1 | 96.0 | 1000 | IRAK3 | IRAK3 | 100.0 | 1000 | IRAK4 | IRAK4 | 100.0 | 1000 | ITK | ITK | 100.0 | 1000 | JAK1 | JAK1(JH2domain-pseudokinase) | 88.0 | 1000 | JAK2 | JAK2(JH1domain-catalytic) | 79.0 | 1000 | JAK3 | JAK3(JH1domain-catalytic) | 73.0 | 1000 | MAPK8 | JNK1 | 87.0 | 1000 | MAPK9 | JNK2 | 80.0 | 1000 | MAPK10 | JNK3 | 95.0 | 1000 | KIT | KIT-autoinhibited | 82.0 | 1000 | LATS1 | LATS1 | 57.0 | 1000 | LATS2 | LATS2 | 100.0 | 1000 | LCK | LCK | 100.0 | 1000 | LIMK1 | LIMK1 | 90.0 | 1000 | LIMK2 | LIMK2 | 64.0 | 1000 | STK11 | LKB1 | 100.0 | 1000 | STK10 | LOK | 98.0 | 1000 | LRRK2 | LRRK2(G2019S) | 84.0 | 1000 | LTK | LTK | 100.0 | 1000 | LYN | LYN | 96.0 | 1000 | MAP3K13 | LZK | 75.0 | 1000 | MAK | MAK | 93.0 | 1000 | MAP3K1 | MAP3K1 | 80.0 | 1000 | MAP3K15 | MAP3K15 | 99.0 | 1000 | MAP3K2 | MAP3K2 | 100.0 | 1000 | MAP3K3 | MAP3K3 | 85.0 | 1000 | MAP3K4 | MAP3K4 | 99.0 | 1000 | MAP4K2 | MAP4K2 | 98.0 | 1000 | MAP4K3 | MAP4K3 | 100.0 | 1000 | MAP4K4 | MAP4K4 | 97.0 | 1000 | MAP4K5 | MAP4K5 | 95.0 | 1000 | MAPKAPK2 | MAPKAPK2 | 100.0 | 1000 | MAPKAPK5 | MAPKAPK5 | 87.0 | 1000 | MARK1 | MARK1 | 100.0 | 1000 | MARK2 | MARK2 | 92.0 | 1000 | MARK3 | MARK3 | 100.0 | 1000 | MARK4 | MARK4 | 100.0 | 1000 | MAST1 | MAST1 | 100.0 | 1000 | MAP2K1 | MEK1 | 93.0 | 1000 | MAP2K2 | MEK2 | 89.0 | 1000 | MAP2K3 | MEK3 | 82.0 | 1000 | MAP2K4 | MEK4 | 83.0 | 1000 | MAP2K5 | MEK5 | 100.0 | 1000 | MAP2K6 | MEK6 | 100.0 | 1000 | MELK | MELK | 84.0 | 1000 | MERTK | MERTK | 97.0 | 1000 | MET | MET(Y1235D) | 99.0 | 1000 | MINK1 | MINK | 78.0 | 1000 | MAP2K7 | MKK7 | 91.0 | 1000 | MKNK1 | MKNK1 | 73.0 | 1000 | MKNK2 | MKNK2 | 87.0 | 1000 | MYLK3 | MLCK | 87.0 | 1000 | MAP3K9 | MLK1 | 93.0 | 1000 | MAP3K10 | MLK2 | 100.0 | 1000 | MAP3K11 | MLK3 | 100.0 | 1000 | CDC42BPA | MRCKA | 90.0 | 1000 | CDC42BPB | MRCKB | 97.0 | 1000 | STK4 | MST1 | 95.0 | 1000 | MST1R | MST1R | 91.0 | 1000 | STK3 | MST2 | 100.0 | 1000 | STK24 | MST3 | 74.0 | 1000 | STK26 | MST4 | 81.0 | 1000 | MTOR | MTOR | 100.0 | 1000 | MUSK | MUSK | 97.0 | 1000 | MYLK | MYLK | 100.0 | 1000 | MYLK2 | MYLK2 | 93.0 | 1000 | MYLK4 | MYLK4 | 100.0 | 1000 | MYO3A | MYO3A | 100.0 | 1000 | MYO3B | MYO3B | 52.0 | 1000 | STK38 | NDR1 | 83.0 | 1000 | STK38L | NDR2 | 100.0 | 1000 | NEK1 | NEK1 | 100.0 | 1000 | NEK10 | NEK10 | 96.0 | 1000 | NEK11 | NEK11 | 81.0 | 1000 | NEK2 | NEK2 | 97.0 | 1000 | NEK3 | NEK3 | 100.0 | 1000 | NEK4 | NEK4 | 72.0 | 1000 | NEK5 | NEK5 | 55.0 | 1000 | NEK6 | NEK6 | 92.0 | 1000 | NEK7 | NEK7 | 100.0 | 1000 | NEK9 | NEK9 | 100.0 | 1000 | MAP3K14 | NIK | 82.0 | 1000 | NIM1K | NIM1 | 81.0 | 1000 | NLK | NLK | 100.0 | 1000 | OXSR1 | OSR1 | 79.0 | 1000 | MAPK14 | p38-alpha | 100.0 | 1000 | MAPK11 | p38-beta | 98.0 | 1000 | MAPK13 | p38-delta | 100.0 | 1000 | MAPK12 | p38-gamma | 100.0 | 1000 | PAK1 | PAK1 | 98.0 | 1000 | PAK2 | PAK2 | 100.0 | 1000 | PAK3 | PAK3 | 77.0 | 1000 | PAK4 | PAK4 | 91.0 | 1000 | PAK6 | PAK6 | 83.0 | 1000 | PAK5 | PAK7 | 88.0 | 1000 | CDK16 | PCTK1 | 89.0 | 1000 | CDK17 | PCTK2 | 90.0 | 1000 | CDK18 | PCTK3 | 100.0 | 1000 | PDGFRA | PDGFRA | 76.0 | 1000 | PDGFRB | PDGFRB | 100.0 | 1000 | PDPK1 | PDPK1 | 100.0 | 1000 | CDPK1 | PFCDPK1(P.falciparum) | 64.0 | 1000 | PK5 | PFPK5(P.falciparum) | 97.0 | 1000 | CDK15 | PFTAIRE2 | 93.0 | 1000 | CDK14 | PFTK1 | 92.0 | 1000 | PHKG1 | PHKG1 | 97.0 | 1000 | PHKG2 | PHKG2 | 74.0 | 1000 | PIK3C2B | PIK3C2B | 94.0 | 1000 | PIK3C2G | PIK3C2G | 78.0 | 1000 | PIK3CA | PIK3CA(Q546K) | 80.0 | 1000 | PIK3CB | PIK3CB | 92.0 | 1000 | PIK3CD | PIK3CD | 90.0 | 1000 | PIK3CG | PIK3CG | 73.0 | 1000 | PI4KB | PIK4CB | 100.0 | 1000 | PIKFYVE | PIKFYVE | 91.0 | 1000 | PIM1 | PIM1 | 89.0 | 1000 | PIM2 | PIM2 | 99.0 | 1000 | PIM3 | PIM3 | 95.0 | 1000 | PIP5K1A | PIP5K1A | 90.0 | 1000 | PIP5K1C | PIP5K1C | 100.0 | 1000 | PIP4K2B | PIP5K2B | 80.0 | 1000 | PIP4K2C | PIP5K2C | 94.0 | 1000 | PRKACA | PKAC-alpha | 100.0 | 1000 | PRKACB | PKAC-beta | 100.0 | 1000 | PKMYT1 | PKMYT1 | 100.0 | 1000 | PKN1 | PKN1 | 100.0 | 1000 | PKN2 | PKN2 | 100.0 | 1000 | PKNB | PKNB(M.tuberculosis) | 98.0 | 1000 | PLK1 | PLK1 | 95.0 | 1000 | PLK2 | PLK2 | 86.0 | 1000 | PLK3 | PLK3 | 88.0 | 1000 | PLK4 | PLK4 | 82.0 | 1000 | PRKCD | PRKCD | 100.0 | 1000 | PRKCE | PRKCE | 97.0 | 1000 | PRKCH | PRKCH | 100.0 | 1000 | PRKCI | PRKCI | 80.0 | 1000 | PRKCQ | PRKCQ | 100.0 | 1000 | PRKD1 | PRKD1 | 96.0 | 1000 | PRKD2 | PRKD2 | 100.0 | 1000 | PRKD3 | PRKD3 | 86.0 | 1000 | PRKG1 | PRKG1 | 97.0 | 1000 | PRKG2 | PRKG2 | 83.0 | 1000 | EIF2AK2 | PRKR | 100.0 | 1000 | PRKX | PRKX | 89.0 | 1000 | PRPF4B | PRP4 | 100.0 | 1000 | PTK2B | PYK2 | 97.0 | 1000 | SIK3 | QSK | 89.0 | 1000 | RAF1 | RAF1 | 100.0 | 1000 | RET | RET(V804M) | 94.0 | 1000 | RIOK1 | RIOK1 | 100.0 | 1000 | RIOK2 | RIOK2 | 98.0 | 1000 | RIOK3 | RIOK3 | 100.0 | 1000 | RIPK1 | RIPK1 | 55.0 | 1000 | RIPK2 | RIPK2 | 84.0 | 1000 | RIPK4 | RIPK4 | 100.0 | 1000 | DSTYK | RIPK5 | 82.0 | 1000 | ROCK1 | ROCK1 | 81.0 | 1000 | ROCK2 | ROCK2 | 84.0 | 1000 | ROS1 | ROS1 | 90.0 | 1000 | RPS6KA4 | RPS6KA4(Kin.Dom.2-C-terminal) | 90.0 | 1000 | RPS6KA5 | RPS6KA5(Kin.Dom.2-C-terminal) | 97.0 | 1000 | RPS6KA1 | RSK1(Kin.Dom.2-C-terminal) | 77.0 | 1000 | RPS6KA3 | RSK2(Kin.Dom.2-C-terminal) | 76.0 | 1000 | RPS6KA2 | RSK3(Kin.Dom.2-C-terminal) | 81.0 | 1000 | RPS6KA6 | RSK4(Kin.Dom.2-C-terminal) | 76.0 | 1000 | RPS6KB1 | S6K1 | 79.0 | 1000 | SBK1 | SBK1 | 81.0 | 1000 | SGK1 | SGK | 75.0 | 1000 | SBK3 | SgK110 | 85.0 | 1000 | SGK2 | SGK2 | 69.0 | 1000 | SGK3 | SGK3 | 69.0 | 1000 | SIK1 | SIK | 100.0 | 1000 | SIK2 | SIK2 | 96.0 | 1000 | SLK | SLK | 100.0 | 1000 | NUAK2 | SNARK | 73.0 | 1000 | SNRK | SNRK | 87.0 | 1000 | SRC | SRC | 100.0 | 1000 | SRMS | SRMS | 90.0 | 1000 | SRPK1 | SRPK1 | 94.0 | 1000 | SRPK2 | SRPK2 | 100.0 | 1000 | SRPK3 | SRPK3 | 93.0 | 1000 | STK16 | STK16 | 87.0 | 1000 | STK33 | STK33 | 69.0 | 1000 | STK35 | STK35 | 98.0 | 1000 | STK36 | STK36 | 88.0 | 1000 | STK39 | STK39 | 78.0 | 1000 | SYK | SYK | 100.0 | 1000 | MAP3K7 | TAK1 | 97.0 | 1000 | TAOK1 | TAOK1 | 100.0 | 1000 | TAOK2 | TAOK2 | 91.0 | 1000 | TAOK3 | TAOK3 | 100.0 | 1000 | TBK1 | TBK1 | 100.0 | 1000 | TEC | TEC | 96.0 | 1000 | TESK1 | TESK1 | 100.0 | 1000 | TGFBR1 | TGFBR1 | 64.0 | 1000 | TGFBR2 | TGFBR2 | 96.0 | 1000 | TIE1 | TIE1 | 96.0 | 1000 | TEK | TIE2 | 86.0 | 1000 | TLK1 | TLK1 | 77.0 | 1000 | TLK2 | TLK2 | 100.0 | 1000 | TNIK | TNIK | 100.0 | 1000 | TNK1 | TNK1 | 93.0 | 1000 | TNK2 | TNK2 | 90.0 | 1000 | TNNI3K | TNNI3K | 84.0 | 1000 | NTRK1 | TRKA | 97.0 | 1000 | NTRK2 | TRKB | 100.0 | 1000 | NTRK3 | TRKC | 91.0 | 1000 | TRPM6 | TRPM6 | 77.0 | 1000 | TSSK1B | TSSK1B | 100.0 | 1000 | TSSK3 | TSSK3 | 81.0 | 1000 | TTK | TTK | 100.0 | 1000 | TXK | TXK | 100.0 | 1000 | TYK2 | TYK2(JH2domain-pseudokinase) | 81.0 | 1000 | TYRO3 | TYRO3 | 94.0 | 1000 | ULK1 | ULK1 | 77.0 | 1000 | ULK2 | ULK2 | 76.0 | 1000 | ULK3 | ULK3 | 83.0 | 1000 | KDR | VEGFR2 | 72.0 | 1000 | PIK3C3 | VPS34 | 88.0 | 1000 | VRK2 | VRK2 | 59.0 | 1000 | WEE1 | WEE1 | 95.0 | 1000 | WEE2 | WEE2 | 87.0 | 1000 | WNK1 | WNK1 | 91.0 | 1000 | WNK2 | WNK2 | 88.0 | 1000 | WNK3 | WNK3 | 94.0 | 1000 | WNK4 | WNK4 | 80.0 | 1000 | STK32A | YANK1 | 85.0 | 1000 | STK32B | YANK2 | 100.0 | 1000 | STK32C | YANK3 | 100.0 | 1000 | YES1 | YES | 90.0 | 1000 | STK25 | YSK1 | 100.0 | 1000 | MAP3K19 | YSK4 | 93.0 | 1000 | MAP3K20 | ZAK | 100.0 | 1000 | ZAP70 | ZAP70 | 94.0 | 1000 |
|---|
A-192621
Compound binding was calculated as a % inhibition of the binding of a radioactively labeled ligand specific for each target. Results showing an inhibition higher than 50 % are considered to represent significant effects of the probe. The results are expressed as a percent inhibition of control specific activity: 100-((measured specific activity/ control specific activity) * 100). Low to moderate negative values have no real meaning and are attributable to variability of the signal around the control level. High negative values (≥ 50 %) that are sometimes obtained with high concentrations of test compounds are generally attributable to nonspecific effects of the test compounds in the assays.
Conclusion: Closest off targets for the probe at 10 µM are BZD (72.1%), CCK1 (63.1%) Cl- channel (77.4%) . At 10 µM the probe inhibits also ETA.
| Target protein | HGNC name | Species | Cmp. conc. | Mean [% Inhibition of Control Specific Binding] | First measurement | Second measurement | Reference compound name | Reference compound IC50 [nM] | Assay ID |
|---|---|---|---|---|---|---|---|---|---|
| A1 (h) | ADORA1 | Homo sapiens | 10 µM | 8.3 | 14.70 | 1.80 | DPCPX | 1.10 | Cerep_2 |
| A2A (h) | ADORA2A | Homo sapiens | 10 µM | -4.8 | -7.00 | -2.60 | NECA | 49.00 | Cerep_4 |
| A2B (h) | ADORA2B | Homo sapiens | 10 µM | -6.1 | -15.30 | 3.00 | NECA | 600.00 | Cerep_5 |
| A3 (h) | ADORA3 | Homo sapiens | 10 µM | 47.4 | 49.20 | 45.70 | IB-MECA | 0.78 | Cerep_6 |
| Alpha1A (h) | ADRA1A | Homo sapiens | 10 µM | 5.0 | 9.50 | 0.50 | WB 4101 | 0.26 | Cerep_2338 |
| Alpha1B (h) | ADRA1B | Homo sapiens | 10 µM | 3.2 | -0.40 | 6.80 | prazosin | 0.21 | Cerep_1633 |
| Alpha2A (h) | ADRA2A | Homo sapiens | 10 µM | 0.0 | -2.40 | 2.30 | yohimbine | 5.40 | Cerep_13 |
| Alpha2B (h) | ADRA2B | Homo sapiens | 10 µM | 7.4 | 19.80 | -5.00 | yohimbine | 7.70 | Cerep_1344 |
| Beta1 (h) | ADRB1 | Homo sapiens | 10 µM | 1.4 | -4.20 | 6.90 | atenolol | 720.00 | Cerep_18 |
| Beta2 (h) | ADRB2 | Homo sapiens | 10 µM | -0.2 | -2.60 | 2.20 | ICI 118551 | 0.91 | Cerep_20 |
| AT1 (h) | AGTR1 | Homo sapiens | 10 µM | 1.5 | -1.30 | 4.30 | saralasin | 0.97 | Cerep_24 |
| AT2 (h) | AGTR2 | Homo sapiens | 10 µM | 2.5 | 9.00 | -3.90 | angiotensin-II | 0.08 | Cerep_26 |
| BZD (central) | Rattus norvegicus | 10 µM | -35.5 | -33.90 | -37.10 | diazepam | 13.00 | Old_Cerep_37 | |
| BZD (peripheral) | Rattus norvegicus | 10 µM | 72.1 | 73.60 | 70.60 | PK 11195 | 2.10 | Old_Cerep_10 | |
| B2 (h) | BDKRB2 | Homo sapiens | 10 µM | -8.6 | -7.40 | -9.80 | NPC 567 | 15.00 | Cerep_33 |
| CGRP (h) | CALCRL | Homo sapiens | 10 µM | -6.1 | -12.50 | 0.30 | hCGRP alpha | 0.04 | Cerep_373 |
| CB1 (h) | CNR1 | Homo sapiens | 10 µM | 15.4 | 18.90 | 11.90 | CP 55940 | 1.40 | Cerep_4708 |
| CB2 (h) | CNR2 | Homo sapiens | 10 µM | 33.6 | 31.20 | 36.10 | WIN 55212-2 | 2.60 | Cerep_37 |
| CCK1 (CCKA) (h) | CCKAR | Homo sapiens | 10 µM | 63.1 | 57.20 | 69.00 | CCK-8s | 0.19 | Cerep_39 |
| D1 (h) | DRD1 | Homo sapiens | 10 µM | -2.2 | -3.80 | -0.70 | SCH 23390 | 0.55 | Cerep_44 |
| D2S (h) | DRD2 | Homo sapiens | 10 µM | 2.6 | 3.50 | 1.70 | (+)butaclamol | 2.60 | Old_Cerep_1322 |
| ETA (h) | EDNRA | Homo sapiens | 10 µM | 97.1 | 95.70 | 98.50 | endothelin-1 | 0.08 | Cerep_54 |
| ETB (h) | EDNRB | Homo sapiens | 10 µM | 94.7 | 99.40 | 90.10 | endothelin-3 | 0.07 | Cerep_56 |
| GABAA1 (h) (alpha1,beta2,gamma2) | GABRA1 | Homo sapiens | 10 µM | -34.0 | -30.20 | -37.70 | muscimol | 96.00 | Cerep_3051 |
| NMDA | Rattus norvegicus | 10 µM | 3.3 | 9.00 | -2.40 | CGS 19755 | 260.00 | Cerep_66 | |
| TNF-alpha (h) | TNFRSF1A | Homo sapiens | 10 µM | 3.4 | -1.10 | 7.90 | TNF-alpha | 0.09 | Cerep_76 |
| H1 (h) | HRH1 | Homo sapiens | 10 µM | -4.4 | 3.60 | -12.40 | pyrilamine | 2.90 | Cerep_870 |
| H2 (h) | HRH2 | Homo sapiens | 10 µM | -35.3 | -50.30 | -20.30 | cimetidine | 380.00 | Cerep_1208 |
| MT2 (ML1B) (h) | MTNR1B | Homo sapiens | 10 µM | 2.4 | -1.90 | 6.70 | melatonin | 0.23 | Cerep_1687 |
| MAO-A | MAOA | Rattus norvegicus | 10 µM | 7.9 | 2.80 | 13.10 | clorgyline | 2.00 | Cerep_443 |
| motilin (h) | MLNR | Homo sapiens | 10 µM | -17.9 | -17.90 | -17.90 | [Nleu13]-motilin | 90.00 | Cerep_470 |
| M1 (h) | CHRM1 | Homo sapiens | 10 µM | -11.2 | -11.00 | -11.40 | pirenzepine | 25.00 | Cerep_91 |
| M2 (h) | CHRM2 | Homo sapiens | 10 µM | -8.8 | -3.90 | -13.60 | methoctramine | 42.00 | Cerep_93 |
| M3 (h) | CHRM3 | Homo sapiens | 10 µM | -11.3 | -7.60 | -15.00 | 4-DAMP | 0.97 | Cerep_95 |
| M4 (h) | CHRM4 | Homo sapiens | 10 µM | -2.0 | -11.70 | 7.70 | 4-DAMP | 1.60 | Cerep_96 |
| M5 (h) | CHRM5 | Homo sapiens | 10 µM | 10.0 | 7.20 | 12.80 | 4-DAMP | 1.30 | Cerep_97 |
| NK1 (h) | TACR1 | Homo sapiens | 10 µM | 36.7 | 37.10 | 36.30 | [Sar9,Met(O2)11]-SP | 0.29 | Cerep_100 |
| NK2 (h) | TACR2 | Homo sapiens | 10 µM | 18.3 | 15.10 | 21.40 | [Nleu10]-NKA (4-10) | 3.00 | Cerep_102 |
| Y1 (h) | NPY1R | Homo sapiens | 10 µM | -9.3 | -10.80 | -7.80 | NPY | 0.24 | Cerep_106 |
| delta (DOP) (h) | OPRD1 | Homo sapiens | 10 µM | 33.5 | 35.20 | 31.70 | DPDPE | 2.40 | Cerep_114 |
| kappa (h) (KOP) | OPRK1 | Homo sapiens | 10 µM | 31.9 | 38.00 | 25.80 | U50488 | 0.47 | Cerep_4461 |
| mu (MOP) (h) | OPRM1 | Homo sapiens | 10 µM | 8.3 | 12.50 | 4.20 | DAMGO | 1.00 | Cerep_118 |
| PPARgamma (h) | PPARG | Homo sapiens | 10 µM | 40.3 | 46.90 | 33.70 | rosiglitazone | 12.00 | Cerep_641 |
| PCP | Rattus norvegicus | 10 µM | -1.5 | -8.90 | 5.90 | MK 801 | 12.00 | Old_Cerep_32 | |
| EP2 (h) | PTGER2 | Homo sapiens | 10 µM | 10.1 | -3.90 | 24.20 | PGE2 | 4.20 | Cerep_1955 |
| P2X | Rattus norvegicus | 10 µM | -2.8 | -13.30 | 7.70 | alpha,beta-MeATP | 2.40 | Old_Cerep_127 | |
| 5-HT1A (h) | HTR1A | Homo sapiens | 10 µM | -5.9 | -2.30 | -9.60 | 8-OH-DPAT | 1.20 | Cerep_131 |
| 5-HT1B(h) | HTR1B | Homo sapiens | 10 µM | 12.3 | 10.10 | 14.50 | Serotonine | 260.00 | Cerep_4376 |
| 5-HT2A (h) | HTR2A | Homo sapiens | 10 µM | 5.5 | 12.90 | -1.90 | ketanserin | 1.10 | Cerep_135 |
| 5-HT2B (h) | HTR2B | Homo sapiens | 10 µM | -1.9 | 2.20 | -6.00 | (±)DOI | 1.80 | Cerep_1333 |
| 5-HT2C (h) | HTR2C | Homo sapiens | 10 µM | 1.2 | -0.40 | 2.90 | RS 102221 | 4.80 | Cerep_137 |
| 5-HT3 (h) | HTR3A | Homo sapiens | 10 µM | -10.7 | -8.90 | -12.50 | MDL 72222 | 11.00 | Cerep_411 |
| 5-HT4 e (h) | HTR4 | Homo sapiens | 10 µM | -12.4 | -17.10 | -7.70 | serotonin | 120.00 | Cerep_501 |
| 5-HT7 (h) | HTR7 | Homo sapiens | 10 µM | 1.9 | -2.00 | 5.90 | serotonin | 1.10 | Cerep_144 |
| sigma (non-selective) (h) | Homo sapiens | 10 µM | 39.3 | 35.10 | 43.60 | haloperidol | 120.00 | Cerep_3500 | |
| GR (h) | NR3C1 | Homo sapiens | 10 µM | 7.0 | 9.00 | 5.10 | dexamethasone | 2.40 | Cerep_469 |
| Estrogen ER alpha (h) | ESR1 | Homo sapiens | 10 µM | -1.1 | -1.30 | -0.90 | Diethylstilbestrol | 0.49 | Cerep_5484 |
| AR (h) | AR | Homo sapiens | 10 µM | -11.6 | -12.10 | -11.00 | testosterone | 5.90 | Cerep_933 |
| UT (h) | UTS2R | Homo sapiens | 10 µM | 23.9 | 26.90 | 20.90 | urotensin-II | 0.79 | Cerep_1386 |
| VPAC1 (VIP1) (h) | VIPR1 | Homo sapiens | 10 µM | -7.7 | -3.00 | -12.50 | VIP | 0.36 | Cerep_157 |
| V1 a (h) | AVPR1A | Homo sapiens | 10 µM | 7.4 | -0.80 | 15.60 | [d(CH2)5 1,Tyr(Me)2]-AVP | 2.10 | Cerep_159 |
| Ca2+ channel (L, dihydropyridine site) | Rattus norvegicus | 10 µM | 30.3 | 37.30 | 23.30 | nitrendipine | 0.16 | Cerep_161 | |
| Ca2+ channel (L, diltiazem site) (benzothiazepines) | CACNA1C | Rattus norvegicus | 10 µM | 4.2 | -9.50 | 18.00 | diltiazem | 39.00 | Cerep_162 |
| KATP channel | Rattus norvegicus | 10 µM | 11.1 | 11.50 | 10.70 | glibenclamide | 0.22 | Old_Cerep_38 | |
| SKCa channel | Rattus norvegicus | 10 µM | 0.5 | -3.10 | 4.00 | apamin | 0.02 | Cerep_167 | |
| Na+ channel (site 2) | Rattus norvegicus | 10 µM | 29.1 | 23.70 | 34.60 | veratridine | 9500.00 | Old_Cerep_169 | |
| Cl- channel (GABA-gated) | Rattus norvegicus | 10 µM | 77.4 | 74.90 | 79.90 | picrotoxinin | 230.00 | Old_Cerep_16 | |
| norepinephrine transporter (h) | SLC6A2 | Homo sapiens | 10 µM | 16.2 | 13.70 | 18.60 | protriptyline | 5.30 | Cerep_355 |
| dopamine transporter (h) | SLC6A3 | Homo sapiens | 10 µM | 23.6 | 28.60 | 18.50 | BTCP | 7.60 | Cerep_52 |
| GABA transporter | Rattus norvegicus | 10 µM | -12.0 | -16.50 | -7.50 | nipecotic acid | 2600.00 | Cerep_60 | |
| 5-HT transporter (h) | SCL6A4 | Homo sapiens | 10 µM | -7.7 | -6.70 | -8.60 | imipramine | 2.00 | Cerep_439 |
A-1806262
Conclusion: The control inhibits the same off targets as the probe: BZD (54.7%), CCK1 (75.9%) Cl- channel (60.8%) and in addition, kappa (54.1%) and PPARγ (67.0%).
| Target protein | HGNC name | Species | Cmp. conc. | Mean [% Inhibition of Control Specific Binding] | First measurement | Second measurement | Reference compound name | Reference compound IC50 [nM] | Assay ID |
|---|---|---|---|---|---|---|---|---|---|
| A1 (h) | ADORA1 | Homo sapiens | 10 µM | 4.2 | 12.1 | -3.6 | DPCPX | 1.1 | Cerep_2 |
| A2A (h) | ADORA2A | Homo sapiens | 10 µM | -12.4 | -7.4 | -17.3 | NECA | 49.0 | Cerep_4 |
| A2B (h) | ADORA2B | Homo sapiens | 10 µM | -8.6 | -3.0 | -14.3 | NECA | 600.0 | Cerep_5 |
| A3 (h) | ADORA3 | Homo sapiens | 10 µM | 37.6 | 41.3 | 33.8 | IB-MECA | 0.8 | Cerep_6 |
| Alpha1A (h) | ADRA1A | Homo sapiens | 10 µM | 3.7 | 5.5 | 1.9 | WB 4101 | 0.3 | Cerep_2338 |
| Alpha1B (h) | ADRA1B | Homo sapiens | 10 µM | 3.1 | -2.3 | 8.4 | prazosin | 0.2 | Cerep_1633 |
| Alpha2A (h) | ADRA2A | Homo sapiens | 10 µM | -7.1 | -5.5 | -8.6 | yohimbine | 5.4 | Cerep_13 |
| Alpha2B (h) | ADRA2B | Homo sapiens | 10 µM | 1.5 | 8.4 | -5.4 | yohimbine | 7.7 | Cerep_1344 |
| Beta1 (h) | ADRB1 | Homo sapiens | 10 µM | 8.2 | -3.8 | 20.2 | atenolol | 720.0 | Cerep_18 |
| Beta2 (h) | ADRB2 | Homo sapiens | 10 µM | 3.6 | 2.5 | 4.6 | ICI 118551 | 0.9 | Cerep_20 |
| AT1 (h) | AGTR1 | Homo sapiens | 10 µM | -3.8 | -5.5 | -2.2 | saralasin | 1.0 | Cerep_24 |
| AT2 (h) | AGTR2 | Homo sapiens | 10 µM | 20.8 | 23.7 | 18.0 | angiotensin-II | 0.1 | Cerep_26 |
| BZD (central) | Rattus norvegicus | 10 µM | -12.9 | -19.1 | -6.8 | diazepam | 13.0 | Old_Cerep_37 | |
| BZD (peripheral) | Rattus norvegicus | 10 µM | 54.7 | 59.4 | 50.0 | PK 11195 | 2.1 | Old_Cerep_10 | |
| B2 (h) | BDKRB2 | Homo sapiens | 10 µM | -12.3 | -13.7 | -11.0 | NPC 567 | 15.0 | Cerep_33 |
| CGRP (h) | CALCRL | Homo sapiens | 10 µM | -0.3 | 3.0 | -3.5 | hCGRPalpha | 0.0 | Cerep_373 |
| CB1 (h) | CNR1 | Homo sapiens | 10 µM | -1.6 | -11.2 | 8.0 | CP 55940 | 1.4 | Cerep_4708 |
| CB2 (h) | CNR2 | Homo sapiens | 10 µM | 14.6 | 10.5 | 18.7 | WIN 55212-2 | 2.6 | Cerep_37 |
| CCK1 (CCKA) (h) | CCKAR | Homo sapiens | 10 µM | 75.9 | 72.3 | 79.4 | CCK-8s | 0.2 | Cerep_39 |
| D1 (h) | DRD1 | Homo sapiens | 10 µM | -0.2 | -5.8 | 5.3 | SCH 23390 | 0.6 | Cerep_44 |
| D2S (h) | DRD2 | Homo sapiens | 10 µM | 1.8 | -5.9 | 9.6 | (+)butaclamol | 2.6 | Old_Cerep_1322 |
| ETA (h) | EDNRA | Homo sapiens | 10 µM | 63.7 | 64.9 | 62.4 | endothelin-1 | 0.1 | Cerep_54 |
| ETB (h) | EDNRB | Homo sapiens | 10 µM | 96.7 | 97.3 | 96.1 | endothelin-3 | 0.1 | Cerep_56 |
| GABAA1 (h) (alpha1,beta2,gamma2) | GABRA1 | Homo sapiens | 10 µM | -33.6 | -22.2 | -45.0 | muscimol | 96.0 | Cerep_3051 |
| NMDA | Rattus norvegicus | 10 µM | 6.6 | -0.8 | 14.0 | CGS 19755 | 260.0 | Cerep_66 | |
| TNF-alpha (h) | TNFRSF1A | Homo sapiens | 10 µM | 1.2 | 2.9 | -0.6 | TNF-alpha | 0.1 | Cerep_76 |
| H1 (h) | HRH1 | Homo sapiens | 10 µM | -10.0 | -11.0 | -9.0 | pyrilamine | 2.9 | Cerep_870 |
| H2 (h) | HRH2 | Homo sapiens | 10 µM | -18.1 | -10.2 | -26.0 | cimetidine | 380.0 | Cerep_1208 |
| MT2 (ML1B) (h) | MTNR1B | Homo sapiens | 10 µM | -3.1 | -2.5 | -3.7 | melatonin | 0.2 | Cerep_1687 |
| MAO-A | MAOA | Rattus norvegicus | 10 µM | 9.9 | 10.3 | 9.6 | clorgyline | 2.0 | Cerep_443 |
| motilin (h | MLNR | Homo sapiens | 10 µM | 4.4 | 3.5 | 5.3 | [Nleu13]-motilin | 90.0 | Cerep_470 |
| M1 (h) | CHRM1 | Homo sapiens | 10 µM | 3.7 | -2.2 | 9.7 | pirenzepine | 25.0 | Cerep_91 |
| M2 (h) | CHRM2 | Homo sapiens | 10 µM | -7.1 | -12.8 | -1.3 | methoctramine | 42.0 | Cerep_93 |
| M3 (h) | CHRM3 | Homo sapiens | 10 µM | -0.6 | -12.3 | 11.1 | 4-DAMP | 1.0 | Cerep_95 |
| M4 (h) | CHRM4 | Homo sapiens | 10 µM | -1.8 | -6.9 | 3.4 | 4-DAMP | 1.6 | Cerep_96 |
| M5 (h) | CHRM5 | Homo sapiens | 10 µM | 0.9 | -8.4 | 10.2 | 4-DAMP | 1.3 | Cerep_97 |
| NK1 (h) | TACR1 | Homo sapiens | 10 µM | 32.2 | 41.5 | 22.9 | [Sar9,Met(O2)11]-SP | 0.3 | Cerep_100 |
| NK2 (h) | TACR2 | Homo sapiens | 10 µM | -3.0 | -4.5 | -1.5 | [Nleu10]-NKA (4-10) | 3.0 | Cerep_102 |
| Y1 (h) | NPY1R | Homo sapiens | 10 µM | -5.6 | -9.5 | -1.7 | NPY | 0.2 | Cerep_106 |
| delta (DOP) (h) | OPRD1 | Homo sapiens | 10 µM | 23.5 | 24.7 | 22.2 | DPDPE | 2.4 | Cerep_114 |
| kappa (h) (KOP) | OPRK1 | Homo sapiens | 10 µM | 54.1 | 53.9 | 54.4 | U50488 | 0.5 | Cerep_4461 |
| mu (MOP) (h) | OPRM1 | Homo sapiens | 10 µM | 11.1 | 2.4 | 19.9 | DAMGO | 1.0 | Cerep_118 |
| PPARgamma (h) | PPARG | Homo sapiens | 10 µM | 67.0 | 71.2 | 62.9 | rosiglitazone | 12.0 | Cerep_641 |
| PCP | Rattus norvegicus | 10 µM | 0.2 | -7.7 | 8.1 | MK 801 | 12.0 | Old_Cerep_32 | |
| EP2 (h) | PTGER2 | Homo sapiens | 10 µM | 10.7 | 5.7 | 15.7 | PGE2 | 4.2 | Cerep_1955 |
| P2X | Rattus norvegicus | 10 µM | 13.4 | 15.1 | 11.7 | alpha,beta-MeATP | 2.4 | Old_Cerep_127 | |
| 5-HT1A (h) | HTR1A | Homo sapiens | 10 µM | -3.8 | -4.7 | -2.9 | 8-OH-DPAT | 1.2 | Cerep_131 |
| 5-HT1B(h) | HTR1B | Homo sapiens | 10 µM | 13.4 | 15.4 | 11.4 | Serotonine | 260.0 | Cerep_4376 |
| 5-HT2A (h) | HTR2A | Homo sapiens | 10 µM | -2.9 | -8.3 | 2.4 | ketanserin | 1.1 | Cerep_135 |
| 5-HT2B (h) | HTR2B | Homo sapiens | 10 µM | -16.5 | -18.2 | -14.8 | (±)DOI | 1.8 | Cerep_1333 |
| 5-HT2C (h) | HTR2C | Homo sapiens | 10 µM | 0.0 | RS 102221 | 4.8 | Cerep_137 | ||
| 5-HT3 (h) | HTR3A | Homo sapiens | 10 µM | -7.1 | -9.1 | -5.1 | MDL 72222 | 11.0 | Cerep_411 |
| 5-HT4 e (h) | HTR4 | Homo sapiens | 10 µM | -13.4 | -12.3 | -14.6 | serotonin | 120.0 | Cerep_501 |
| 5-HT7 (h) | HTR7 | Homo sapiens | 10 µM | 0.4 | -2.5 | 3.4 | serotonin | 1.1 | Cerep_144 |
| sigma (non-selective) (h) | Homo sapiens | 10 µM | -9.7 | -7.5 | -11.8 | haloperidol | 120.0 | Cerep_3500 | |
| GR (h) | NR3C1 | Homo sapiens | 10 µM | 4.1 | 7.2 | 0.9 | dexamethasone | 2.4 | Cerep_469 |
| Estrogen ER alpha (h) | ESR1 | Homo sapiens | 10 µM | -0.8 | -3.4 | 1.8 | Diethylstilbestrol | 0.5 | Cerep_5484 |
| AR (h) | AR | Homo sapiens | 10 µM | -11.6 | -12.5 | -10.6 | testosterone | 5.9 | Cerep_933 |
| UT (h) | UTS2R | Homo sapiens | 10 µM | 9.4 | 12.6 | 6.2 | urotensin-II | 0.8 | Cerep_1386 |
| VPAC1 (VIP1) (h) | VIPR1 | Homo sapiens | 10 µM | -1.5 | -7.9 | 4.9 | VIP | 0.4 | Cerep_157 |
| V1 a (h) | AVPR1A | Homo sapiens | 10 µM | 15.0 | 3.9 | 26.1 | [d(CH2)5 1,Tyr(Me)2]-AVP | 2.1 | Cerep_159 |
| Ca2+ channel (L, dihydropyridine site) | Rattus norvegicus | 10 µM | 27.2 | 24.8 | 29.6 | nitrendipine | 0.2 | Cerep_161 | |
| Ca2+ channel (L, diltiazem site) (benzothiazepines) | CACNA1C | Rattus norvegicus | 10 µM | 15.4 | 14.7 | 16.1 | diltiazem | 39.0 | Cerep_162 |
| KATP channel | Rattus norvegicus | 10 µM | 6.0 | 2.9 | 9.2 | glibenclamide | 0.2 | Old_Cerep_38 | |
| SKCa channel | Rattus norvegicus | 10 µM | -2.0 | -3.1 | -1.0 | apamin | 0.0 | Cerep_167 | |
| Na+ channel (site 2) | Rattus norvegicus | 10 µM | 24.4 | 21.6 | 27.1 | veratridine | 9500.0 | Old_Cerep_169 | |
| Cl- channel (GABA-gated) | Rattus norvegicus | 10 µM | 60.8 | 59.8 | 61.7 | picrotoxinin | 230.0 | Old_Cerep_16 | |
| norepinephrine transporter (h) | SLC6A2 | Homo sapiens | 10 µM | 1.6 | -0.7 | 3.9 | protriptyline | 5.3 | Cerep_355 |
| dopamine transporter (h) | SLC6A3 | Homo sapiens | 10 µM | 18.3 | 12.1 | 24.5 | BTCP | 7.6 | Cerep_52 |
| GABA transporter | Rattus norvegicus | 10 µM | -17.3 | -20.3 | -14.3 | nipecotic acid | 2600.0 | Cerep_60 | |
| 5-HT transporter (h) | SCL6A4 | Homo sapiens | 10 µM | 5.2 | 1.9 | 8.4 | imipramine | 2.0 | Cerep_439 |
A-192621
Results showing an inhibition higher than 50 % are considered to represent significant effects of the probe. The results are expressed as a percent inhibition of control specific activity: 100-((measured specific activity/ control specific activity) * 100). Low to moderate negative values have no real meaning and are attributable to variability of the signal around the control level. High negative values (≥ 50%) that are sometimes obtained with high concentrations of test compounds are generally attributable to nonspecific effects of the test compounds in the assays.
Conclusion: Clean Eurofins-Cerep panel for the tested enyzmes at 10 µM.
| Target protein | HGNC name | Species | Cmp. conc. | Mean [% Inhibition of Control Values] | First measurement | Second measurement | Reference compound name | Reference compound IC50 [nM] | Assay ID |
|---|---|---|---|---|---|---|---|---|---|
| COX1(h) | PTGS1 | Homo sapiens | 10 µM | 13.2 | 12.60 | 13.80 | Diclofenac | 12.00 | Cerep_4173 |
| COX2(h) | PTGS2 | Homo sapiens | 10 µM | 44.0 | 43.40 | 44.50 | NS398 | 180.00 | Cerep_4186 |
| PDE3A (h) | PDE3A | Homo sapiens | 10 µM | 29.0 | 32.10 | 25.90 | milrinone | 1400.00 | Cerep_4072 |
| ACE (h) | ACE | Homo sapiens | 10 µM | -12.6 | -13.50 | -11.80 | captopril | 0.62 | Cerep_3441 |
| Acetylcholinesterase (h) | ACHE | Homo sapiens | 10 µM | 7.0 | 7.90 | 6.10 | galanthamine | 630.00 | Cerep_363 |
| MAO-B (h) recombinant enzyme | MAOB | Homo sapiens | 10 µM | -12.3 | -15.40 | -9.30 | deprenyl | 25.00 | Cerep_3477 |
| ATPase (Na+/K+) | Sus scrofa | 10 µM | 0.7 | -0.40 | 1.90 | ouabain | 320.00 | Cerep_2009 |
A-1806262
Conclusion: Clean Eurofins-Cerep panel for the tested enyzmes at 10 µM.
| Target protein | HGNC name | Species | Cmp. conc. | Mean [% Inhibition of Control Values] | First measurement | Second measurement | Reference compound name | Reference compound IC50 [nM] | Assay ID |
|---|---|---|---|---|---|---|---|---|---|
| COX1(h) | PTGS1 | Homo sapiens | 10 µM | 2.3 | 3.9 | 0.6 | Diclofenac | 12.0 | Cerep_4173 |
| COX2(h) | PTGS2 | Homo sapiens | 10 µM | 34.0 | 37.6 | 30.4 | NS398 | 180.0 | Cerep_4186 |
| PDE3A (h) | PDE3A | Homo sapiens | 10 µM | 34.5 | 44.3 | 24.7 | milrinone | 1400.0 | Cerep_4072 |
| ACE (h) | ACE | Homo sapiens | 10 µM | -13.7 | -16.0 | -11.3 | captopril | 0.6 | Cerep_3441 |
| Acetylcholinesterase (h) | ACHE | Homo sapiens | 10 µM | 4.0 | 3.1 | 4.9 | galanthamine | 630.0 | Cerep_363 |
| MAO-B (h) recombinant enzyme | MAOB | Homo sapiens | 10 µM | -14.5 | -16.8 | -12.1 | deprenyl | 25.0 | Cerep_3477 |
| ATPase (Na+/K+) | Sus scrofa | 10 µM | 0.6 | 0.6 | 0.6 | ouabain | 320.0 | Cerep_2009 |